Skip to main content

Cochlear Implant Users

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cochlear
CochlearAustralia - Macquarie Park
1 program
Nucleus 8 Sound Processor streaming via MultiMic+N/A1 trial
Active Trials
NCT07262827Recruiting20Est. Oct 2027

Trial Timeline

Clinical trial activity over time

2026
2027
CochlearNucleus 8 Sound Processor streaming via MultiMic+

Clinical Trials (1)

Total enrollment: 20 patients across 1 trials

NCT07262827CochlearNucleus 8 Sound Processor streaming via MultiMic+

Investigating the Acceptance and Performance of Low Energy Audio Streaming in Nucleus 8 and Kanso 3 Sound Processors by Experienced Cochlear Implant Users

Start: Mar 2026Est. completion: Oct 202720 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 20 patients
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.